Advanced Therapies Week 2026 is the leading cell and gene therapy conference in the United States, bringing 2,000+ biotech, pharma, CDMO, and investment leaders to San Diego for four days of networking, innovation, and deal-making.

SLAS2026 delivers a fast-paced exhibition experience, including opportunities for business-to-business and business-to-consumer interactions.

Now in its 17th year, SCOPE returns February 2–5, 2026, to Rosen Shingle Creek in Orlando, Florida, bringing together the full clinical research ecosystem for four high-impact days of discussion, strategy, and networking.

The 2026 ISPE Facilities of the Future Conference brings together pharmaceutical industry stakeholders, particularly those concerned with planning, designing, constructing, manufacturing, supplying, and assessing innovative “next generation” facilities and related pharmaceutical engineering innovations, processes, and practices.

The 5th mRNA-Based Therapeutics Summit Europe is the ultimate biopharma platform diving into novel mRNA, sa-RNA and circular RNA design to delivery innovations, giving you the latest insights and connections to turn these breakthroughs into action.

Drawing on a decade of industry experience, the 10th Microbiome Movement Summit Europe returns to London as the premiere touchpoint for end-to-end discussions in advancing best-in-class microbiome products beyond traditional gastrointestinal indications.

The Festival focusses on AI, biodata, cancer diagnostics, drug discovery, genomic medicine, multi-omics, single-cell, spatial, women’s health….and so much more!

Returning as the industry’s only dedicated meeting, the 4th Molecular Glue Drug Development Summit brings top experts from biopharma and academia together for intimate networking and scientific content sharing. Designed to address the unique challenges of molecular glues, this meeting will provide actionable strategies to accelerate the development of safer, more selective candidates toward the clinic.

Returning as the industry's premier dedicated forum, the 7th RNAi-Based Therapeutics Summit is the only event uniting the entire RNA interference ecosystem to translate the next wave of siRNA and microRNA drugs from bench to bedside.

The WCBP Scientific Organizing Committee, which includes individuals representing industry, academia, and regulatory agencies, is looking forward to welcoming everyone. From first-time attendees to those who have attended in previous years, WCBP 2026 will offer something for everyone.

The 4th Ophthalmic Drug Delivery Summit arrives at a pivotal moment, bringing together 80+ leading experts from pharma and biotech to tackle the toughest delivery hurdles limiting the impact of cutting-edge therapeutics.

Returning to Boston for its 9th year, the DDR Inhibitors Summit is the definitive meeting for senior decision-makers driving innovation in DNA Damage Response (DDR)-targeted oncology. With PARP inhibitors clinically validated for almost a decade, the field is now on the cusp of the next inhibitor class approval.

Pharmapack 2026 is a two-day international event where professionals from the pharmaceutical and medical device industries come together to showcase, explore, and discuss innovations in drug packaging and drug delivery.

The Second Annual BioLogic Summit, presented by the experienced team behind PEGS and PepTalk, will bring together the biologics community to unlock the potential of ML/AI in design and development.

This premier gathering continues to place the pharmaceutical and biotech sectors at the very heart of its foundation - championing the legal strategies, regulatory updates, and innovation shaping the future of IP protection in life sciences.

Join a vibrant community of scientists, trailblazers, and industry leaders at PepTalk 2026, as they mark 25 years of accelerating breakthroughs in biotherapeutic discovery and development.

At Fierce JPM Week 2026, the sector’s most influential leaders, investors and policymakers will convene to confront these questions and chart the course ahead.

Kick off 2026 and set the tone for the year at 18th Annual Pre-Filled Syringes and Injectable Drug Devices Conference!

This event will unite leaders and innovators from the device development industry. This highly anticipated conference offers unparalleled opportunities to explore the latest advances in combination product technology, share insights, and foster collaboration across a dynamic three-day program.

Join them for the ESACT-UK 2026 Conference that will be held on the 7th and 8th January 2026 in Oxford, UK. You can expect high-profile speakers such as Dr. Ioscani Jimenez del Val (UCD), Dr. Yusuf Johari (Lonza), Prof Gary Lye (UCL) and Prof. David James (University of Sheffield), and exciting talks across sessions.

The Drug Delivery to the Lungs Conference (DDL) is in it’s 36th year and attracts in excess of 1100 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts.

The 2nd ADC Pharmacokinetics & Clinical Pharmacology Summit brings together experts in PKPD, bioanalysis, pharmacometrics, and clinical pharmacology to share novel data and real-world case studies.

With late-phase trials advancing, novel mechanisms emerging, and global regulatory expectations evolving, the dry AMD and GA field is accelerating exponentially. Returning digitally for its sixth year, this summit is the only industry-led forum focused exclusively on the therapeutic development for dry AMD and GA.

The 2025 ISPE Pharma 4.0™ Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on digital transformation, automation, and the evolving landscape and future of Pharma 4.0™.

Join 100+ industry experts spanning neuroscientists, chemists, device engineers, conjugation scientists, DMPK experts, delivery specialists, and more at the 7th CNS Drug Delivery Summit to collaborate, network, and learn cutting-edge strategies that are tackling the unique challenges in gaining access to the brain.

SynbiTECH is the UK’s leading international forum for people engaged in engineering biology business, investment, policymaking, science and research.

The 3rd Covalent Drug Discovery & Development Summit returns as the premier industry forum for experts to accelerate the discovery, translation and development of covalent drugs, driving the next wave of first- and best-in-class therapeutics against previously undruggable targets.